SCPH - צמיחת הכנסות משנה לשנה ב-12 החודשים האחרונים scpharmaceuticals.com

The year-over-year sales volume growth trajectory for TTM on the GURU.Markets chart shows that 0.00 is the current metric. Effective supply for home heart systems supports distribution channel margins. However, trade conflicts and electronics shortages create export risks. Meanwhile, insurance company savings on hospitalizations guarantee scPharmaceuticals Inc. (SCPH) premium pricing.
פילוחי נתונים אנליטיים מרוכזים עבור scPharmaceuticals Inc. (SCPH)

The resilience of scPharmaceuticals Inc. (SCPH) is driven by the countercyclical demand for heart failure treatments, rendering the current trailing twelve months (TTM) sales dynamics an indicator of the company's effectiveness in navigating FDA approval cycles. This metric measures the percentage change in revenue over a rolling twelve-month period, allowing investors to assess the actual pace of business expansion and determine the fairness of the market capitalization through the lens of sales scaling.